Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Salary Range: CHF142,100.00 - CHF263,900.00 Job Description Summary LI#- Hybrid Location: Basel, Switzerland As a Therapeutic Area Biomarker Lead (TABL) in the Biomarker Development (BMD) group, you are accountable for defining and delivering biomarker strategies for
Postdoctoral Researcher in Multimodal Reasoning Models for Oncology We are seeking an exceptional and highly motivated Postdoctoral Researcher to lead research on multimodal reasoning models for oncology. The project focuses on developing, post‑training, and evaluating flexible
To reinforce our teams in Basel, Switzerland, we are seeking independent research fellows hosted at the Centre for Pathogen Bioinformatics. Overview The Centre for Pathogen Bioinformatics (CPB) hosts young researchers during their fellowships in the Basel
Overview We are seeking an exceptional and highly motivated Postdoctoral Researcher to lead research on multimodal reasoning models for oncology. The project focuses on developing, post-training, and evaluating flexible AI models that can support complex oncologic
We are seeking an exceptional and highly motivated Postdoctoral Researcher to lead research on multimodal reasoning models for oncology. The project focuses on developing, post-training, and evaluating flexible AI models that can support complex oncologic diagnostic
Overview Bruker enables scientists and engineers to make groundbreaking post-genomic discoveries and develop new applications that improve people’s quality of life. Bruker’s high-performance scientific instruments and high-quality analytical and diagnostic solutions allow scientists to explore life and
About RocheAt Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Responsibilities The Hunt: Origination & Pipeline Building Targeted Prospecting: Systematically map the global Biopharma landscape (especially in Rare Diseases, Targeted Oncology, and Immunology) to identify active Phase 2b/3 pipelines that are bottlenecked by patient recruitment. Evangelizing
Description The Centre for Pathogen Bioinformatics (CPB) hosts young researchers during their fellowships in the Basel area. With the groups of ,, , and all based in the Basel life science hub, we offer a world-class